Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis

EBV‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This entity can be labeled as primary age‐related EBV‐associated EBL and appears to respond well to rituximab and thoracentesis.

Detalles Bibliográficos
Autores principales: Kuhlman, Justin J., Alhaj Moustafa, Muhamad, Tun, Alexander J., Menke, David M., Tun, Han W., Jiang, Liuyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162398/
https://www.ncbi.nlm.nih.gov/pubmed/34094552
http://dx.doi.org/10.1002/ccr3.3971
_version_ 1783700703728893952
author Kuhlman, Justin J.
Alhaj Moustafa, Muhamad
Tun, Alexander J.
Menke, David M.
Tun, Han W.
Jiang, Liuyan
author_facet Kuhlman, Justin J.
Alhaj Moustafa, Muhamad
Tun, Alexander J.
Menke, David M.
Tun, Han W.
Jiang, Liuyan
author_sort Kuhlman, Justin J.
collection PubMed
description EBV‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This entity can be labeled as primary age‐related EBV‐associated EBL and appears to respond well to rituximab and thoracentesis.
format Online
Article
Text
id pubmed-8162398
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81623982021-06-03 Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis Kuhlman, Justin J. Alhaj Moustafa, Muhamad Tun, Alexander J. Menke, David M. Tun, Han W. Jiang, Liuyan Clin Case Rep Case Report EBV‐positive HHV8‐negative EBL is part of the spectrum of EBV‐positive diffuse large B‐cell lymphoma NOS. This entity can be labeled as primary age‐related EBV‐associated EBL and appears to respond well to rituximab and thoracentesis. John Wiley and Sons Inc. 2021-04-04 /pmc/articles/PMC8162398/ /pubmed/34094552 http://dx.doi.org/10.1002/ccr3.3971 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Kuhlman, Justin J.
Alhaj Moustafa, Muhamad
Tun, Alexander J.
Menke, David M.
Tun, Han W.
Jiang, Liuyan
Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
title Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
title_full Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
title_fullStr Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
title_full_unstemmed Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
title_short Primary age‐related EBV‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
title_sort primary age‐related ebv‐associated effusion‐based lymphoma successfully treated with rituximab and thoracentesis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162398/
https://www.ncbi.nlm.nih.gov/pubmed/34094552
http://dx.doi.org/10.1002/ccr3.3971
work_keys_str_mv AT kuhlmanjustinj primaryagerelatedebvassociatedeffusionbasedlymphomasuccessfullytreatedwithrituximabandthoracentesis
AT alhajmoustafamuhamad primaryagerelatedebvassociatedeffusionbasedlymphomasuccessfullytreatedwithrituximabandthoracentesis
AT tunalexanderj primaryagerelatedebvassociatedeffusionbasedlymphomasuccessfullytreatedwithrituximabandthoracentesis
AT menkedavidm primaryagerelatedebvassociatedeffusionbasedlymphomasuccessfullytreatedwithrituximabandthoracentesis
AT tunhanw primaryagerelatedebvassociatedeffusionbasedlymphomasuccessfullytreatedwithrituximabandthoracentesis
AT jiangliuyan primaryagerelatedebvassociatedeffusionbasedlymphomasuccessfullytreatedwithrituximabandthoracentesis

Ejemplares similares